Table 1.
Code | R1 | R2 | Inhibition Percentage a | CC50 (μM) b |
---|---|---|---|---|
1 | p-CH3C6H4SO2 | - | 18.5% ± 1.1% | >320 |
5a | p-CF3C6H4SO2 | - | −3.7% ± 3.0% | NT c |
5b | C6H5CH2 | - | −33.6% ± 10.6% | NT c |
5c | p-CH3C6H4CH2 | - | −116.2% ± 45.7% | NT c |
5d | p-BrC6H4CH2 | - | 6.4%± 0.9% | NT c |
6a | p-CH3C6H4SO2 | NH2 | 21.2% ± 10.4% | >320 |
6b | p-CH3C6H4SO2 | NHCH3 | 12.8% ± 7.3% | NT c |
6c | p-CH3C6H4SO2 | NHCH(CH3)2 | −84.2% ± 63.1% | NT c |
6d | p-CH3C6H4SO2 | N(CH3)2 | −36.7% ± 17.3% | NT c |
6e | p-CH3C6H4SO2 | NHPh | 69.0% ± 13.5% | 82.55 |
6f | p-CF3C6H4SO2 | NH2 | −19.0% ± 7.8% | NT c |
6g | p-CF3C6H4SO2 | NHCH3 | 6.1% ± 0.8% | NT c |
6h | p-CF3C6H4SO2 | N(CH3)2 | −35.2% ± 2.1% | NT c |
6i | C6H5CH2 | NH2 | 47.8% ± 29.0% | >320 |
6j | C6H5CH2 | NHCH3 | 29.5% ± 6.1% | NT c |
6k | C6H5CH2 | N(CH3)2 | 15.2% ± 7.1% | NT c |
6l | p-CH3C6H4CH2 | NH2 | 38.7% ± 4.4% | >320 |
6m | p-CH3C6H4CH2 | NHCH3 | −29.6% ± 13.6% | NT c |
6n | p-CH3C6H4CH2 | N(CH3)2 | 39.7%± 12.3% | >320 |
6o | p-BrC6H4CH2 | NH2 | 7.8% ± 3.0% | NT c |
7a | p-CH3C6H4SO2 | NHCOCH3 | 33.9% ± 9.9% | NT c |
7b | p-CF3C6H4SO2 | NHCOCH3 | −6.0% ± 5.0% | NT c |
7c | C6H5CH2 | NHCOCH3 | 12.9% ± 10.6% | NT c |
7d | p-CH3C6H4CH2 | NHCOCH3 | 27.0% ± 9.5% | NT c |
EGCG | - | - | 27.5% ± 7.9% | - |
DMSO | - | - | 2.9% ± 0 | - |
a The inhibition rate of COL1A1 promotor’s activity in LX2 cells; b Cytotoxic concentration required to inhibit HepG2 cells cell growth by 50%; c Not tested.